Global (United States, European Union and China) Travel Vaccines
Global (United States, European Union and China) Travel Vaccines

Travel Vaccines Comprehensive Study by Type (Hepatitis B Vaccines, Hepatitis A Vaccines, Typhoid and paratyphoid fever., Meningococcal Vaccines, Others), Application (Domestic Travel, Outbound Travel), Diseases (Influenza, Hepatitis, Typhoid, Polio, Yellow fever, Others) Players and Region - Global Market Outlook to 2024

Travel Vaccines Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Dec 2019 Edition 249 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Travel Vaccines Market Scope
Travel vaccines protect travelers from serious diseases. The travel vaccines market is expected to grow in the future due to the increasing number of travelers throughout the globe. Increasing incidence of travel-related diseases and government initiatives to ensure travel safety boosting the demand for travel vaccines. Rising investments towards the research and development of more effective vaccines provide new growth opportunities in the near future.

The market study is being classified by Type (Hepatitis B Vaccines, Hepatitis A Vaccines, Typhoid and paratyphoid fever., Meningococcal Vaccines and Others), by Application (Domestic Travel and Outbound Travel) and major geographies with country level break-up.

Research Analyst at AMA predicts that Global Players will contribute to the maximum growth of Global Travel Vaccines market throughout the predicted period.

Pfizer Inc. (United States), Sanofi S.A (France), GlaxoSmithKline plc (United Kingdom), Merck & Co., Inc. (United States), AstraZeneca plc (United Kingdom), Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Takeda Pharmaceutical Company Ltd (Japan), Bausch Health Companies Inc. (Canada), SK Chemicals (South Korea) and Bavarian Nordic (Denmark) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Hualan Biological Engineering Inc. (China) and Serum Institute of India (India).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Travel Vaccines market by Type, Application and Region.

On the basis of geography, the market of Travel Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In Oct 2019, Bavarian Nordic announced that it has entered an agreement with GlaxoSmithKline plc to acquire the manufacturing and global rights to Rabipur®/RabAvert® and Encepur®. Rabipur/RabAvert provides pre- and post-exposure protection against rabies, while Encepur protects against European (Western) tick-borne encephalitis (TBE) virus.
In Dec 2018, The U.S. Food and Drug Administration has approved VAXELIS(TM) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday). VAXELIS was developed as part of a joint-partnership between Sanofi and MSD.


Market Trend
  • Governments Initiatives to Ensure Travel Safety
  • Increasing Incidence of Travel-Related Diseases

Market Drivers
  • Increasing Number of Travelers throughout the Globe
  • Rising Prevalence of Infectious Diseases

Opportunities
  • Rising Investments towards the Research and Development for More Effective Vaccines
  • Growth in Tourism Industry in Developing Countries

Restraints
  • Travel Vaccines are Expensive

Challenges
  • Longer Timelines Required for Vaccine Production
  • Stringent Government Regulation


Key Target Audience
Travel Vaccines Manufacturer, Travel Vaccines Suppliers/Distributors, Raw Material Suppliers, Pharmaceutical Industry, Potential Investors and Research and Development Firm

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Hepatitis B Vaccines
  • Hepatitis A Vaccines
  • Typhoid and paratyphoid fever.
  • Meningococcal Vaccines
  • Others
By Application
  • Domestic Travel
  • Outbound Travel
By Diseases
  • Influenza
  • Hepatitis
  • Typhoid
  • Polio
  • Yellow fever
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Travelers throughout the Globe
      • 3.2.2. Rising Prevalence of Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. Longer Timelines Required for Vaccine Production
      • 3.3.2. Stringent Government Regulation
    • 3.4. Market Trends
      • 3.4.1. Governments Initiatives to Ensure Travel Safety
      • 3.4.2. Increasing Incidence of Travel-Related Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Travel Vaccines, by Type, Application, Diseases and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Travel Vaccines (Value)
      • 5.2.1. Global Travel Vaccines by: Type (Value)
        • 5.2.1.1. Hepatitis B Vaccines
        • 5.2.1.2. Hepatitis A Vaccines
        • 5.2.1.3. Typhoid and paratyphoid fever.
        • 5.2.1.4. Meningococcal Vaccines
        • 5.2.1.5. Others
      • 5.2.2. Global Travel Vaccines by: Application (Value)
        • 5.2.2.1. Domestic Travel
        • 5.2.2.2. Outbound Travel
      • 5.2.3. Global Travel Vaccines by: Diseases (Value)
        • 5.2.3.1. Influenza
        • 5.2.3.2. Hepatitis
        • 5.2.3.3. Typhoid
        • 5.2.3.4. Polio
        • 5.2.3.5. Yellow fever
        • 5.2.3.6. Others
      • 5.2.4. Global Travel Vaccines Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Travel Vaccines (Volume)
      • 5.3.1. Global Travel Vaccines by: Type (Volume)
        • 5.3.1.1. Hepatitis B Vaccines
        • 5.3.1.2. Hepatitis A Vaccines
        • 5.3.1.3. Typhoid and paratyphoid fever.
        • 5.3.1.4. Meningococcal Vaccines
        • 5.3.1.5. Others
      • 5.3.2. Global Travel Vaccines by: Application (Volume)
        • 5.3.2.1. Domestic Travel
        • 5.3.2.2. Outbound Travel
      • 5.3.3. Global Travel Vaccines by: Diseases (Volume)
        • 5.3.3.1. Influenza
        • 5.3.3.2. Hepatitis
        • 5.3.3.3. Typhoid
        • 5.3.3.4. Polio
        • 5.3.3.5. Yellow fever
        • 5.3.3.6. Others
      • 5.3.4. Global Travel Vaccines Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Travel Vaccines (Price)
      • 5.4.1. Global Travel Vaccines by: Type (Price)
  • 6. Travel Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi S.A (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline plc (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Takeda Pharmaceutical Company Ltd (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bausch Health Companies Inc. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SK Chemicals (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Bavarian Nordic (Denmark)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Travel Vaccines Sale, by Type, Application, Diseases and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Travel Vaccines (Value)
      • 7.2.1. Global Travel Vaccines by: Type (Value)
        • 7.2.1.1. Hepatitis B Vaccines
        • 7.2.1.2. Hepatitis A Vaccines
        • 7.2.1.3. Typhoid and paratyphoid fever.
        • 7.2.1.4. Meningococcal Vaccines
        • 7.2.1.5. Others
      • 7.2.2. Global Travel Vaccines by: Application (Value)
        • 7.2.2.1. Domestic Travel
        • 7.2.2.2. Outbound Travel
      • 7.2.3. Global Travel Vaccines by: Diseases (Value)
        • 7.2.3.1. Influenza
        • 7.2.3.2. Hepatitis
        • 7.2.3.3. Typhoid
        • 7.2.3.4. Polio
        • 7.2.3.5. Yellow fever
        • 7.2.3.6. Others
      • 7.2.4. Global Travel Vaccines Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Travel Vaccines (Volume)
      • 7.3.1. Global Travel Vaccines by: Type (Volume)
        • 7.3.1.1. Hepatitis B Vaccines
        • 7.3.1.2. Hepatitis A Vaccines
        • 7.3.1.3. Typhoid and paratyphoid fever.
        • 7.3.1.4. Meningococcal Vaccines
        • 7.3.1.5. Others
      • 7.3.2. Global Travel Vaccines by: Application (Volume)
        • 7.3.2.1. Domestic Travel
        • 7.3.2.2. Outbound Travel
      • 7.3.3. Global Travel Vaccines by: Diseases (Volume)
        • 7.3.3.1. Influenza
        • 7.3.3.2. Hepatitis
        • 7.3.3.3. Typhoid
        • 7.3.3.4. Polio
        • 7.3.3.5. Yellow fever
        • 7.3.3.6. Others
      • 7.3.4. Global Travel Vaccines Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Travel Vaccines (Price)
      • 7.4.1. Global Travel Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Travel Vaccines: by Type(USD Million)
  • Table 2. Travel Vaccines Hepatitis B Vaccines , by Region USD Million (2013-2018)
  • Table 3. Travel Vaccines Hepatitis A Vaccines , by Region USD Million (2013-2018)
  • Table 4. Travel Vaccines Typhoid and paratyphoid fever. , by Region USD Million (2013-2018)
  • Table 5. Travel Vaccines Meningococcal Vaccines , by Region USD Million (2013-2018)
  • Table 6. Travel Vaccines Others , by Region USD Million (2013-2018)
  • Table 7. Travel Vaccines: by Application(USD Million)
  • Table 8. Travel Vaccines Domestic Travel , by Region USD Million (2013-2018)
  • Table 9. Travel Vaccines Outbound Travel , by Region USD Million (2013-2018)
  • Table 10. Travel Vaccines: by Diseases(USD Million)
  • Table 11. Travel Vaccines Influenza , by Region USD Million (2013-2018)
  • Table 12. Travel Vaccines Hepatitis , by Region USD Million (2013-2018)
  • Table 13. Travel Vaccines Typhoid , by Region USD Million (2013-2018)
  • Table 14. Travel Vaccines Polio , by Region USD Million (2013-2018)
  • Table 15. Travel Vaccines Yellow fever , by Region USD Million (2013-2018)
  • Table 16. Travel Vaccines Others , by Region USD Million (2013-2018)
  • Table 17. South America Travel Vaccines, by Country USD Million (2013-2018)
  • Table 18. South America Travel Vaccines, by Type USD Million (2013-2018)
  • Table 19. South America Travel Vaccines, by Application USD Million (2013-2018)
  • Table 20. South America Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 21. Brazil Travel Vaccines, by Type USD Million (2013-2018)
  • Table 22. Brazil Travel Vaccines, by Application USD Million (2013-2018)
  • Table 23. Brazil Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 24. Argentina Travel Vaccines, by Type USD Million (2013-2018)
  • Table 25. Argentina Travel Vaccines, by Application USD Million (2013-2018)
  • Table 26. Argentina Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 27. Rest of South America Travel Vaccines, by Type USD Million (2013-2018)
  • Table 28. Rest of South America Travel Vaccines, by Application USD Million (2013-2018)
  • Table 29. Rest of South America Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 30. Asia Pacific Travel Vaccines, by Country USD Million (2013-2018)
  • Table 31. Asia Pacific Travel Vaccines, by Type USD Million (2013-2018)
  • Table 32. Asia Pacific Travel Vaccines, by Application USD Million (2013-2018)
  • Table 33. Asia Pacific Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 34. China Travel Vaccines, by Type USD Million (2013-2018)
  • Table 35. China Travel Vaccines, by Application USD Million (2013-2018)
  • Table 36. China Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 37. Japan Travel Vaccines, by Type USD Million (2013-2018)
  • Table 38. Japan Travel Vaccines, by Application USD Million (2013-2018)
  • Table 39. Japan Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 40. India Travel Vaccines, by Type USD Million (2013-2018)
  • Table 41. India Travel Vaccines, by Application USD Million (2013-2018)
  • Table 42. India Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 43. South Korea Travel Vaccines, by Type USD Million (2013-2018)
  • Table 44. South Korea Travel Vaccines, by Application USD Million (2013-2018)
  • Table 45. South Korea Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 46. Taiwan Travel Vaccines, by Type USD Million (2013-2018)
  • Table 47. Taiwan Travel Vaccines, by Application USD Million (2013-2018)
  • Table 48. Taiwan Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 49. Australia Travel Vaccines, by Type USD Million (2013-2018)
  • Table 50. Australia Travel Vaccines, by Application USD Million (2013-2018)
  • Table 51. Australia Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Travel Vaccines, by Type USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Travel Vaccines, by Application USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 55. Europe Travel Vaccines, by Country USD Million (2013-2018)
  • Table 56. Europe Travel Vaccines, by Type USD Million (2013-2018)
  • Table 57. Europe Travel Vaccines, by Application USD Million (2013-2018)
  • Table 58. Europe Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 59. Germany Travel Vaccines, by Type USD Million (2013-2018)
  • Table 60. Germany Travel Vaccines, by Application USD Million (2013-2018)
  • Table 61. Germany Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 62. France Travel Vaccines, by Type USD Million (2013-2018)
  • Table 63. France Travel Vaccines, by Application USD Million (2013-2018)
  • Table 64. France Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 65. Italy Travel Vaccines, by Type USD Million (2013-2018)
  • Table 66. Italy Travel Vaccines, by Application USD Million (2013-2018)
  • Table 67. Italy Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 68. United Kingdom Travel Vaccines, by Type USD Million (2013-2018)
  • Table 69. United Kingdom Travel Vaccines, by Application USD Million (2013-2018)
  • Table 70. United Kingdom Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 71. Netherlands Travel Vaccines, by Type USD Million (2013-2018)
  • Table 72. Netherlands Travel Vaccines, by Application USD Million (2013-2018)
  • Table 73. Netherlands Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 74. Rest of Europe Travel Vaccines, by Type USD Million (2013-2018)
  • Table 75. Rest of Europe Travel Vaccines, by Application USD Million (2013-2018)
  • Table 76. Rest of Europe Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 77. MEA Travel Vaccines, by Country USD Million (2013-2018)
  • Table 78. MEA Travel Vaccines, by Type USD Million (2013-2018)
  • Table 79. MEA Travel Vaccines, by Application USD Million (2013-2018)
  • Table 80. MEA Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 81. Middle East Travel Vaccines, by Type USD Million (2013-2018)
  • Table 82. Middle East Travel Vaccines, by Application USD Million (2013-2018)
  • Table 83. Middle East Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 84. Africa Travel Vaccines, by Type USD Million (2013-2018)
  • Table 85. Africa Travel Vaccines, by Application USD Million (2013-2018)
  • Table 86. Africa Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 87. North America Travel Vaccines, by Country USD Million (2013-2018)
  • Table 88. North America Travel Vaccines, by Type USD Million (2013-2018)
  • Table 89. North America Travel Vaccines, by Application USD Million (2013-2018)
  • Table 90. North America Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 91. United States Travel Vaccines, by Type USD Million (2013-2018)
  • Table 92. United States Travel Vaccines, by Application USD Million (2013-2018)
  • Table 93. United States Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 94. Canada Travel Vaccines, by Type USD Million (2013-2018)
  • Table 95. Canada Travel Vaccines, by Application USD Million (2013-2018)
  • Table 96. Canada Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 97. Mexico Travel Vaccines, by Type USD Million (2013-2018)
  • Table 98. Mexico Travel Vaccines, by Application USD Million (2013-2018)
  • Table 99. Mexico Travel Vaccines, by Diseases USD Million (2013-2018)
  • Table 100. Travel Vaccines Sales: by Type(Unit)
  • Table 101. Travel Vaccines Sales Hepatitis B Vaccines , by Region Unit (2013-2018)
  • Table 102. Travel Vaccines Sales Hepatitis A Vaccines , by Region Unit (2013-2018)
  • Table 103. Travel Vaccines Sales Typhoid and paratyphoid fever. , by Region Unit (2013-2018)
  • Table 104. Travel Vaccines Sales Meningococcal Vaccines , by Region Unit (2013-2018)
  • Table 105. Travel Vaccines Sales Others , by Region Unit (2013-2018)
  • Table 106. Travel Vaccines Sales: by Application(Unit)
  • Table 107. Travel Vaccines Sales Domestic Travel , by Region Unit (2013-2018)
  • Table 108. Travel Vaccines Sales Outbound Travel , by Region Unit (2013-2018)
  • Table 109. Travel Vaccines Sales: by Diseases(Unit)
  • Table 110. Travel Vaccines Sales Influenza , by Region Unit (2013-2018)
  • Table 111. Travel Vaccines Sales Hepatitis , by Region Unit (2013-2018)
  • Table 112. Travel Vaccines Sales Typhoid , by Region Unit (2013-2018)
  • Table 113. Travel Vaccines Sales Polio , by Region Unit (2013-2018)
  • Table 114. Travel Vaccines Sales Yellow fever , by Region Unit (2013-2018)
  • Table 115. Travel Vaccines Sales Others , by Region Unit (2013-2018)
  • Table 116. South America Travel Vaccines Sales, by Country Unit (2013-2018)
  • Table 117. South America Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 118. South America Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 119. South America Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 120. Brazil Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 121. Brazil Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 122. Brazil Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 123. Argentina Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 124. Argentina Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 125. Argentina Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 126. Rest of South America Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 127. Rest of South America Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 128. Rest of South America Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 129. Asia Pacific Travel Vaccines Sales, by Country Unit (2013-2018)
  • Table 130. Asia Pacific Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 131. Asia Pacific Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 132. Asia Pacific Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 133. China Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 134. China Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 135. China Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 136. Japan Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 137. Japan Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 138. Japan Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 139. India Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 140. India Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 141. India Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 142. South Korea Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 143. South Korea Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 144. South Korea Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 145. Taiwan Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 146. Taiwan Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 147. Taiwan Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 148. Australia Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 149. Australia Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 150. Australia Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 151. Rest of Asia-Pacific Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 152. Rest of Asia-Pacific Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 153. Rest of Asia-Pacific Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 154. Europe Travel Vaccines Sales, by Country Unit (2013-2018)
  • Table 155. Europe Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 156. Europe Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 157. Europe Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 158. Germany Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 159. Germany Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 160. Germany Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 161. France Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 162. France Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 163. France Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 164. Italy Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 165. Italy Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 166. Italy Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 167. United Kingdom Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 168. United Kingdom Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 169. United Kingdom Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 170. Netherlands Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 171. Netherlands Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 172. Netherlands Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 173. Rest of Europe Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 174. Rest of Europe Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 175. Rest of Europe Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 176. MEA Travel Vaccines Sales, by Country Unit (2013-2018)
  • Table 177. MEA Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 178. MEA Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 179. MEA Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 180. Middle East Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 181. Middle East Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 182. Middle East Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 183. Africa Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 184. Africa Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 185. Africa Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 186. North America Travel Vaccines Sales, by Country Unit (2013-2018)
  • Table 187. North America Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 188. North America Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 189. North America Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 190. United States Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 191. United States Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 192. United States Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 193. Canada Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 194. Canada Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 195. Canada Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 196. Mexico Travel Vaccines Sales, by Type Unit (2013-2018)
  • Table 197. Mexico Travel Vaccines Sales, by Application Unit (2013-2018)
  • Table 198. Mexico Travel Vaccines Sales, by Diseases Unit (2013-2018)
  • Table 199. Travel Vaccines: by Type(USD/Units)
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Travel Vaccines: by Type(USD Million)
  • Table 212. Travel Vaccines Hepatitis B Vaccines , by Region USD Million (2019-2024)
  • Table 213. Travel Vaccines Hepatitis A Vaccines , by Region USD Million (2019-2024)
  • Table 214. Travel Vaccines Typhoid and paratyphoid fever. , by Region USD Million (2019-2024)
  • Table 215. Travel Vaccines Meningococcal Vaccines , by Region USD Million (2019-2024)
  • Table 216. Travel Vaccines Others , by Region USD Million (2019-2024)
  • Table 217. Travel Vaccines: by Application(USD Million)
  • Table 218. Travel Vaccines Domestic Travel , by Region USD Million (2019-2024)
  • Table 219. Travel Vaccines Outbound Travel , by Region USD Million (2019-2024)
  • Table 220. Travel Vaccines: by Diseases(USD Million)
  • Table 221. Travel Vaccines Influenza , by Region USD Million (2019-2024)
  • Table 222. Travel Vaccines Hepatitis , by Region USD Million (2019-2024)
  • Table 223. Travel Vaccines Typhoid , by Region USD Million (2019-2024)
  • Table 224. Travel Vaccines Polio , by Region USD Million (2019-2024)
  • Table 225. Travel Vaccines Yellow fever , by Region USD Million (2019-2024)
  • Table 226. Travel Vaccines Others , by Region USD Million (2019-2024)
  • Table 227. South America Travel Vaccines, by Country USD Million (2019-2024)
  • Table 228. South America Travel Vaccines, by Type USD Million (2019-2024)
  • Table 229. South America Travel Vaccines, by Application USD Million (2019-2024)
  • Table 230. South America Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 231. Brazil Travel Vaccines, by Type USD Million (2019-2024)
  • Table 232. Brazil Travel Vaccines, by Application USD Million (2019-2024)
  • Table 233. Brazil Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 234. Argentina Travel Vaccines, by Type USD Million (2019-2024)
  • Table 235. Argentina Travel Vaccines, by Application USD Million (2019-2024)
  • Table 236. Argentina Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 237. Rest of South America Travel Vaccines, by Type USD Million (2019-2024)
  • Table 238. Rest of South America Travel Vaccines, by Application USD Million (2019-2024)
  • Table 239. Rest of South America Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 240. Asia Pacific Travel Vaccines, by Country USD Million (2019-2024)
  • Table 241. Asia Pacific Travel Vaccines, by Type USD Million (2019-2024)
  • Table 242. Asia Pacific Travel Vaccines, by Application USD Million (2019-2024)
  • Table 243. Asia Pacific Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 244. China Travel Vaccines, by Type USD Million (2019-2024)
  • Table 245. China Travel Vaccines, by Application USD Million (2019-2024)
  • Table 246. China Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 247. Japan Travel Vaccines, by Type USD Million (2019-2024)
  • Table 248. Japan Travel Vaccines, by Application USD Million (2019-2024)
  • Table 249. Japan Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 250. India Travel Vaccines, by Type USD Million (2019-2024)
  • Table 251. India Travel Vaccines, by Application USD Million (2019-2024)
  • Table 252. India Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 253. South Korea Travel Vaccines, by Type USD Million (2019-2024)
  • Table 254. South Korea Travel Vaccines, by Application USD Million (2019-2024)
  • Table 255. South Korea Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 256. Taiwan Travel Vaccines, by Type USD Million (2019-2024)
  • Table 257. Taiwan Travel Vaccines, by Application USD Million (2019-2024)
  • Table 258. Taiwan Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 259. Australia Travel Vaccines, by Type USD Million (2019-2024)
  • Table 260. Australia Travel Vaccines, by Application USD Million (2019-2024)
  • Table 261. Australia Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 262. Rest of Asia-Pacific Travel Vaccines, by Type USD Million (2019-2024)
  • Table 263. Rest of Asia-Pacific Travel Vaccines, by Application USD Million (2019-2024)
  • Table 264. Rest of Asia-Pacific Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 265. Europe Travel Vaccines, by Country USD Million (2019-2024)
  • Table 266. Europe Travel Vaccines, by Type USD Million (2019-2024)
  • Table 267. Europe Travel Vaccines, by Application USD Million (2019-2024)
  • Table 268. Europe Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 269. Germany Travel Vaccines, by Type USD Million (2019-2024)
  • Table 270. Germany Travel Vaccines, by Application USD Million (2019-2024)
  • Table 271. Germany Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 272. France Travel Vaccines, by Type USD Million (2019-2024)
  • Table 273. France Travel Vaccines, by Application USD Million (2019-2024)
  • Table 274. France Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 275. Italy Travel Vaccines, by Type USD Million (2019-2024)
  • Table 276. Italy Travel Vaccines, by Application USD Million (2019-2024)
  • Table 277. Italy Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 278. United Kingdom Travel Vaccines, by Type USD Million (2019-2024)
  • Table 279. United Kingdom Travel Vaccines, by Application USD Million (2019-2024)
  • Table 280. United Kingdom Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 281. Netherlands Travel Vaccines, by Type USD Million (2019-2024)
  • Table 282. Netherlands Travel Vaccines, by Application USD Million (2019-2024)
  • Table 283. Netherlands Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 284. Rest of Europe Travel Vaccines, by Type USD Million (2019-2024)
  • Table 285. Rest of Europe Travel Vaccines, by Application USD Million (2019-2024)
  • Table 286. Rest of Europe Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 287. MEA Travel Vaccines, by Country USD Million (2019-2024)
  • Table 288. MEA Travel Vaccines, by Type USD Million (2019-2024)
  • Table 289. MEA Travel Vaccines, by Application USD Million (2019-2024)
  • Table 290. MEA Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 291. Middle East Travel Vaccines, by Type USD Million (2019-2024)
  • Table 292. Middle East Travel Vaccines, by Application USD Million (2019-2024)
  • Table 293. Middle East Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 294. Africa Travel Vaccines, by Type USD Million (2019-2024)
  • Table 295. Africa Travel Vaccines, by Application USD Million (2019-2024)
  • Table 296. Africa Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 297. North America Travel Vaccines, by Country USD Million (2019-2024)
  • Table 298. North America Travel Vaccines, by Type USD Million (2019-2024)
  • Table 299. North America Travel Vaccines, by Application USD Million (2019-2024)
  • Table 300. North America Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 301. United States Travel Vaccines, by Type USD Million (2019-2024)
  • Table 302. United States Travel Vaccines, by Application USD Million (2019-2024)
  • Table 303. United States Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 304. Canada Travel Vaccines, by Type USD Million (2019-2024)
  • Table 305. Canada Travel Vaccines, by Application USD Million (2019-2024)
  • Table 306. Canada Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 307. Mexico Travel Vaccines, by Type USD Million (2019-2024)
  • Table 308. Mexico Travel Vaccines, by Application USD Million (2019-2024)
  • Table 309. Mexico Travel Vaccines, by Diseases USD Million (2019-2024)
  • Table 310. Travel Vaccines Sales: by Type(Unit)
  • Table 311. Travel Vaccines Sales Hepatitis B Vaccines , by Region Unit (2019-2024)
  • Table 312. Travel Vaccines Sales Hepatitis A Vaccines , by Region Unit (2019-2024)
  • Table 313. Travel Vaccines Sales Typhoid and paratyphoid fever. , by Region Unit (2019-2024)
  • Table 314. Travel Vaccines Sales Meningococcal Vaccines , by Region Unit (2019-2024)
  • Table 315. Travel Vaccines Sales Others , by Region Unit (2019-2024)
  • Table 316. Travel Vaccines Sales: by Application(Unit)
  • Table 317. Travel Vaccines Sales Domestic Travel , by Region Unit (2019-2024)
  • Table 318. Travel Vaccines Sales Outbound Travel , by Region Unit (2019-2024)
  • Table 319. Travel Vaccines Sales: by Diseases(Unit)
  • Table 320. Travel Vaccines Sales Influenza , by Region Unit (2019-2024)
  • Table 321. Travel Vaccines Sales Hepatitis , by Region Unit (2019-2024)
  • Table 322. Travel Vaccines Sales Typhoid , by Region Unit (2019-2024)
  • Table 323. Travel Vaccines Sales Polio , by Region Unit (2019-2024)
  • Table 324. Travel Vaccines Sales Yellow fever , by Region Unit (2019-2024)
  • Table 325. Travel Vaccines Sales Others , by Region Unit (2019-2024)
  • Table 326. South America Travel Vaccines Sales, by Country Unit (2019-2024)
  • Table 327. South America Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 328. South America Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 329. South America Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 330. Brazil Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 331. Brazil Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 332. Brazil Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 333. Argentina Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 334. Argentina Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 335. Argentina Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 336. Rest of South America Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 337. Rest of South America Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 338. Rest of South America Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 339. Asia Pacific Travel Vaccines Sales, by Country Unit (2019-2024)
  • Table 340. Asia Pacific Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 341. Asia Pacific Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 342. Asia Pacific Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 343. China Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 344. China Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 345. China Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 346. Japan Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 347. Japan Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 348. Japan Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 349. India Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 350. India Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 351. India Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 352. South Korea Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 353. South Korea Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 354. South Korea Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 355. Taiwan Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 356. Taiwan Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 357. Taiwan Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 358. Australia Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 359. Australia Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 360. Australia Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 361. Rest of Asia-Pacific Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 362. Rest of Asia-Pacific Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 363. Rest of Asia-Pacific Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 364. Europe Travel Vaccines Sales, by Country Unit (2019-2024)
  • Table 365. Europe Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 366. Europe Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 367. Europe Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 368. Germany Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 369. Germany Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 370. Germany Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 371. France Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 372. France Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 373. France Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 374. Italy Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 375. Italy Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 376. Italy Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 377. United Kingdom Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 378. United Kingdom Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 379. United Kingdom Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 380. Netherlands Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 381. Netherlands Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 382. Netherlands Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 383. Rest of Europe Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 384. Rest of Europe Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 385. Rest of Europe Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 386. MEA Travel Vaccines Sales, by Country Unit (2019-2024)
  • Table 387. MEA Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 388. MEA Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 389. MEA Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 390. Middle East Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 391. Middle East Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 392. Middle East Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 393. Africa Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 394. Africa Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 395. Africa Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 396. North America Travel Vaccines Sales, by Country Unit (2019-2024)
  • Table 397. North America Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 398. North America Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 399. North America Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 400. United States Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 401. United States Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 402. United States Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 403. Canada Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 404. Canada Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 405. Canada Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 406. Mexico Travel Vaccines Sales, by Type Unit (2019-2024)
  • Table 407. Mexico Travel Vaccines Sales, by Application Unit (2019-2024)
  • Table 408. Mexico Travel Vaccines Sales, by Diseases Unit (2019-2024)
  • Table 409. Travel Vaccines: by Type(USD/Units)
  • Table 410. Research Programs/Design for This Report
  • Table 411. Key Data Information from Secondary Sources
  • Table 412. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Travel Vaccines: by Type USD Million (2013-2018)
  • Figure 5. Global Travel Vaccines: by Application USD Million (2013-2018)
  • Figure 6. Global Travel Vaccines: by Diseases USD Million (2013-2018)
  • Figure 7. South America Travel Vaccines Share (%), by Country
  • Figure 8. Asia Pacific Travel Vaccines Share (%), by Country
  • Figure 9. Europe Travel Vaccines Share (%), by Country
  • Figure 10. MEA Travel Vaccines Share (%), by Country
  • Figure 11. North America Travel Vaccines Share (%), by Country
  • Figure 12. Global Travel Vaccines: by Type Unit (2013-2018)
  • Figure 13. Global Travel Vaccines: by Application Unit (2013-2018)
  • Figure 14. Global Travel Vaccines: by Diseases Unit (2013-2018)
  • Figure 15. South America Travel Vaccines Share (%), by Country
  • Figure 16. Asia Pacific Travel Vaccines Share (%), by Country
  • Figure 17. Europe Travel Vaccines Share (%), by Country
  • Figure 18. MEA Travel Vaccines Share (%), by Country
  • Figure 19. North America Travel Vaccines Share (%), by Country
  • Figure 20. Global Travel Vaccines: by Type USD/Units (2013-2018)
  • Figure 21. Global Travel Vaccines share by Players 2018 (%)
  • Figure 22. Global Travel Vaccines share by Players (Top 3) 2018(%)
  • Figure 23. Global Travel Vaccines share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Sanofi S.A (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi S.A (France) Revenue: by Geography 2018
  • Figure 29. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2018
  • Figure 31. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 33. AstraZeneca plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. AstraZeneca plc (United Kingdom) Revenue: by Geography 2018
  • Figure 35. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 36. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 37. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2018
  • Figure 39. Takeda Pharmaceutical Company Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Takeda Pharmaceutical Company Ltd (Japan) Revenue: by Geography 2018
  • Figure 41. Bausch Health Companies Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 42. Bausch Health Companies Inc. (Canada) Revenue: by Geography 2018
  • Figure 43. SK Chemicals (South Korea) Revenue, Net Income and Gross profit
  • Figure 44. SK Chemicals (South Korea) Revenue: by Geography 2018
  • Figure 45. Bavarian Nordic (Denmark) Revenue, Net Income and Gross profit
  • Figure 46. Bavarian Nordic (Denmark) Revenue: by Geography 2018
  • Figure 47. Global Travel Vaccines: by Type USD Million (2019-2024)
  • Figure 48. Global Travel Vaccines: by Application USD Million (2019-2024)
  • Figure 49. Global Travel Vaccines: by Diseases USD Million (2019-2024)
  • Figure 50. South America Travel Vaccines Share (%), by Country
  • Figure 51. Asia Pacific Travel Vaccines Share (%), by Country
  • Figure 52. Europe Travel Vaccines Share (%), by Country
  • Figure 53. MEA Travel Vaccines Share (%), by Country
  • Figure 54. North America Travel Vaccines Share (%), by Country
  • Figure 55. Global Travel Vaccines: by Type Unit (2019-2024)
  • Figure 56. Global Travel Vaccines: by Application Unit (2019-2024)
  • Figure 57. Global Travel Vaccines: by Diseases Unit (2019-2024)
  • Figure 58. South America Travel Vaccines Share (%), by Country
  • Figure 59. Asia Pacific Travel Vaccines Share (%), by Country
  • Figure 60. Europe Travel Vaccines Share (%), by Country
  • Figure 61. MEA Travel Vaccines Share (%), by Country
  • Figure 62. North America Travel Vaccines Share (%), by Country
  • Figure 63. Global Travel Vaccines: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Pfizer Inc. (United States)
  • Sanofi S.A (France)
  • GlaxoSmithKline plc (United Kingdom)
  • Merck & Co., Inc. (United States)
  • AstraZeneca plc (United Kingdom)
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Takeda Pharmaceutical Company Ltd (Japan)
  • Bausch Health Companies Inc. (Canada)
  • SK Chemicals (South Korea)
  • Bavarian Nordic (Denmark)
Additional players considered in the study are as follows:
Hualan Biological Engineering Inc. (China) , Serum Institute of India (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation